After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.

The companies have been embroiled in a row about compounded GLP-1 drugs that escalated to a lawsuit last month. The legal action has now been dropped and the former adversaries have struck a deal that ...

Add Yahoo as a preferred source to see more of our stories on Google. A vial with injectable compound and a syringe. - Anna Hoychuk // Shutterstock Compounded semaglutide is a medication that’s custom ...

Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.

Shares of telehealth company Hims & Hers skyrocketed Monday after the company struck a deal with Danish drugmaker Novo Nordisk to sell its GLP-1 weight-loss medications, ending the feud between the ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...

A Kentucky lawmaker has filed a new bill that would strengthen oversight of compounded drugs, including weight loss ...

The Cost of Weight Loss Drugs With and Without Insurance Key takeaways: Weight loss drugs can cost $200 to $2,000 monthly, depending on the medication. The ...